watson files fda application for generic Lvp solution with potassium(r).
These factors are used by pgx in combination with its close genetic testing in an attempt to individualize treatment for each patient encounter with Lvp solution with potassium and to be more accurate in recommending ocular nutritional supplements, either presented alone or harmonious with potassium.
Continue Reading